With more than 52,000 diagnoses annually in the United Kingdom alone, prostate cancer is one of the most common cancers in men and one of the more stubborn.
Prostate cancer is one of the more stubborn variants of the fatal disease. But that could be about to change, if a treatment devised by University of Miami scientists proves effective. The team said they have developed "the first therapy of its kind that disrupts prostate cancer cells' metabolism and releases cisplatin into the weakened cells." Cisplatin is a chemotherapy drug that in the past has not been effective against prostate cancer, despite it having a track record against testicular, breast, bladder, lung and ovarian cancers.